Miller Anestesia

from the EPILOG and EPISTENT trials. Improve

Long-term Outcome with abciximab GP IIb/IIIa

blockade. Evaluation of Platelet IIb/IIIa Inhibition

in STENTing. Ann Thorac Surg 70:516–526, 2000.

175. Gammie JS, Zenati M, Kormos RL, et al: Abciximab

and excessive bleeding in patients undergoing

emergency cardiac operations. Ann Thorac Surg

65:465–469, 1998.

176. Lemmer JH Jr, Metzdorff MT, Krause AH Jr, et al:

Emergency coronary artery bypass graft surgery in

abciximab-treated patients. Ann Thorac Surg

69:90–95, 2000.

177. Singh M, Nuttall GA, Ballman KV, et al: Effect of

abciximab on the outcome of emergency coronary

artery bypass grafting after failed percutaneous

coronary intervention. Mayo Clin Proc 76:784–788,

2001.

178. Uthoff K, Zehr KJ, Geerling R, et al: Inhibition of

platelet adhesion during cardiopulmonary bypass

reduces postoperative bleeding. Circulation

90:II269–II274, 1994.

179. Marso SP, Bhatt DL, Roe MT, et al: Enhanced effi-

cacy of eptifibatide administration in patients with

acute coronary syndrome requiring in-hospital

coronary artery bypass grafting. PURSUIT Investi-

gators. Circulation 102:2952–2958, 2000.

180. McDonald SB, Renna M, Spitznagel EL, et al: Preo-

perative use of enoxaparin increases the risk of

postoperative bleeding and re-exploration in

cardiacsurgerypatients.JCardiothoracVascAnesth

19:4–10, 2005.

181. Clark SC, Vitale N, Zacharias J, et al: Effect of low

molecular weight heparin (Fragmin) on bleeding

after cardiac surgery. Ann Thorac Surg 69:762–764,

2000.

182. Bar-Yosef S, Cozart HB, Phillips-Bute B, et al: Preo-

perative low molecular weight heparin reduces

heparin responsiveness during cardiac surgery. Can

J Anaesth 54:107–113, 2007.

183. Harle CC, Murkin JM: Another bleeding heart:

Perioperative heparin management revisited. Can J

Anaesth 54:97–102, 2007.

184. Bertrand M, Godet G, Meersschaert K, et al: Should

the angiotensin II antagonists be discontinued

before surgery? Anesth Analg 92:26–30, 2001.

185. Mangano DT: Aspirin and mortality from coronary

bypass surgery. N Engl J Med 347:1309–1317, 2002.

186. Stein PD, Schunemann HJ, Dalen JE, et al: Anti-

thrombotic therapy in patients with saphenous vein

and internal mammary artery bypass grafts: The

Seventh ACCP Conference on Antithrombotic and

Thrombolytic Therapy. Chest 126:600S–608S, 2004.

187. Ferraris VA, Ferraris SP, Moliterno DJ, et al: The

Society of Thoracic Surgeons practice guideline

series: Aspirin and other antiplatelet agents during

operative coronary revascularization (executive

summary). Ann Thorac Surg 79:1454–1461, 2005.

188. Bracey AW, Grigore AM, Nussmeier NA: Impact of

platelet testing on presurgical screening and impli-

cations for cardiac and noncardiac surgical proce-

dures. Am J Cardiol 98:25N–32N, 2006.

189. Cope DK, Impastato WK, Cohen MV, et al: Volatile

anesthetics protect the ischemic rabbit myocardium

from infarction. Anesthesiology 86:699–709, 1997.

190. Belhomme D, Peynet J, Louzy M, et al: Evidence for

preconditioning by isoflurane in coronary artery

bypass graft surgery. Circulation 100:II340–II344,

1999.

191. Zaugg M, Lucchinetti E, Spahn DR, et al: Volatile

anesthetics mimic cardiac preconditioning by

priming the activation of mitochondrial K(ATP)

channels via multiple signaling pathways. Anesthe-

siology 97:4–14, 2002.

192. Conzen PF, Fischer S, Detter C, et al: Sevoflurane

provides greater protection of the myocardium than

propofol in patients undergoing off-pump coronary

artery bypass surgery. Anesthesiology 99:826–833,

2003.

193. Connolly MW: Aortoatriocaval cannulation for car-

diopulmonary bypass. In Mora CT, Guyton RA,

Finlayson DC, et al (eds): Cardiopulmonary Bypass:

Principles and Techniques of Extracorporeal Circu-

lation. New York, Springer, 1995, pp 257–263.

194. Romanoff ME, Royster RL: The postcardiopulmo-

nary bypass period: Weaning to ICU transport.

Hensley FA, Martin DE, Gravlee GP (eds): A Prac-

tical Approach to Cardiac Anesthesia, 4th ed. Phila-

delphia, Lippincott Williams & Wilkins, 2008, pp

230–260.

195. England MR, Gordon G, SalemM, et al: Magnesium

administration and dysrhythmias after cardiac

surgery: A placebo-controlled, double-blind, rando-

mized trial. JAMA 268:2395–2402, 1992.

196. Liu EH, Dhara SS: Monitoring oxygenator expira-

tory isoflurane concentrations and the bispectral

index to guide isoflurane requirements during car-

diopulmonary bypass. J Cardiothorac Vasc Anesth

19:485–487, 2005.

197. Tewari P, Skinner H: Cardiopulmonary bypass

machine can interfere with accuracy of BIS monitor

[reply]. Anesth Analg 105:535, 2007.

198. Dahaba AA: Different conditions that could result

in the bispectral index indicating an incorrect hyp-

notic state. Anesth Analg 101:765–773, 2005.

199. Toller WG, Stranz C: Levosimendan, a new inotro-

pic and vasodilator agent. Anesthesiology 104:556–

569, 2006.

200. Morais RJ: Levosimendan in severe right ventricu-

lar failure following mitral valve replacement. J

Cardiothorac Vasc Anesth 20:82–84, 2006.

201. Siirila-Waris K, Suojaranta-Ylinen R, Harjola VP:

Levosimendan in cardiac surgery. J Cardiothorac

Vasc Anesth 19:345–349, 2005.

202. Moran JL, Gallagher J, Peake SL, et al: Parenteral

magnesium sulfate versus amiodarone in the

therapy of atrial tachyarrhythmias: A prospective,

randomized study. Crit Care Med 23:1816–1824,

1995.

203. Pleym H, Wahba A, Videm V, et al: Increased fibri-

nolysis and platelet activation in elderly patients

undergoing coronary bypass surgery. Anesth Analg

102:660–667, 2006.

204. Parolari A, Guarnieri D, Alamanni F, et al: Platelet

function and anesthetics in cardiac surgery: An in

vitro and ex vivo study. Anesth Analg 89:26–31,

1999.

205. Avidan MS, Alcock EL, Da Fonseca J, et al: Compa-

rison of structured use of routine laboratory tests

or near-patient assessment with clinical judgement

in the management of bleeding after cardiac surgery.

Br J Anaesth 92:178–186, 2004.

206. Despotis GJ, Grishaber JE, Goodnough LT. The

effect of an intraoperative treatment algorithm on

physicians’ transfusion practice in cardiac surgery.

Transfusion (Paris) 34:290–296, 1994.

207. Nuttall GA, Oliver WC, Santrach PJ, et al: Efficacy of

a simple intraoperative transfusion algorithm for

nonerythrocyte component utilization after cardio-

pulmonary bypass. Anesthesiology 94:773–781, 2001.

208. Shore-Lesserson L, Manspeizer HE, DePerio M, et

al: Thromboelastography-guided transfusion algo-

rithm reduces transfusions in complex cardiac

surgery. Anesth Analg 88:312–319, 1999.

209. Metz S, Keats AS: Benefits of a glucose-containing

priming solution for cardiopulmonary bypass.

Anesth Analg 72:428–434, 1991.

210. De Somer F, Francois K, van OeverenW, et al: Phos-

phorylcholine coating of extracorporeal circuits

provides natural protection against blood activation

by the material surface. Eur J Cardiothorac Surg

18:602–606, 2000.

211. Nutter BT, Stammers AH, Schmer RG, et al: The

rheological effects of X-Coating with albumin and

hetastarch on blood during cardiopulmonary

bypass. J Extra Corpor Technol 36:36–43, 2004.

212. Schreurs HH, Wijers MJ, Gu YJ, et al: Heparin-

coated bypass circuits: Effects on inflammatory

response in pediatric cardiac operations. Ann

Thorac Surg 66:166–171, 1998.

213. Ask A, Holt D, Smith L: In vivo comparison study

of FDA-approved surface-modifying additives and

poly-2-methoxyethylacrylate circuit surfaces coa-

tings during cardiopulmonary bypass. J Extra

Corpor Technol 38:27–32, 2006.

214. Linneweber J, Chow TW, Kawamura M, et al: In

vitro comparison of blood pump induced platelet

microaggregates between a centrifugal and roller

pump during cardiopulmonary bypass. Int J Artif

Organs 25:549–555, 2002.

215. Nishinaka T, Nishida H, Endo M, et al: Less blood

damage in the impeller centrifugal pump: A com-

parative study with the roller pump in open heart

surgery. Artif Organs 20:707–710, 1996.

216. Federspiel WJ, Henchir KA: Lung, artificial: Basic

principles and current applications. In Wnek GE,

Bowlin GL (eds): Encyclopedia of Biomaterials and

Biomedical Engineering. New York, Marcel Dekker,

2004, pp 910–921.

217. Fritts HW Jr, Harris P, Chidsey CA III, et al: Estima-

tion of flow through bronchial-pulmonary vascular

anastomoses with use of T-1824 dye. Circulation

23:390–398, 1961.

218. Oriaku G, Xiang B, Dai G, et al: Effects of retrograde

cardioplegia on myocardial perfusion and energy

metabolism in immature porcine myocardium. J

Thorac Cardiovasc Surg 119:1102–1109, 2000.

219. Tian G, Xiang B, Dai G, et al: Retrograde cardiople-

gia. J Thorac Cardiovasc Surg 125:872–880, 2003.

220. Wass CT, Lanier WL, Hofer RE, et al: Temperature

changes of greater than or equal to 1 degree Celsius

alter functional neurologic outcome and histopa-

thology in a canine model of complete cerebral

ischemia. Anesthesiology 83:325–335, 1995.

221. Hindler K, Nussmeier NA: Central nervous system

risk assessment. In Newman M, Fleisher L, Fink M

(eds): Perioperative Medicine: Managing for

Outcome. Philadelphia, Elsevier, 2008, pp 69–88.

222. Fujisawa H, Koizumi H, Ito H, et al: Effects of mild

hypothermia on the cortical release of excitatory

amino acids and nitric oxide synthesis following

hypoxia. J Neurotrauma 16:1083–1093, 1999.

223. Dietrich WD, Busto R, Halley M, et al: The impor-

tance of brain temperature in alterations of the

blood-brain barrier following cerebral ischemia. J

Neuropathol Exp Neurol 49:486–497, 1990.

224. Chen Z, Chen H, Rhee P, et al: Induction of pro-

found hypothermia modulates the immune/inflam-

matory response in a swine model of lethal

hemorrhage. Resuscitation 66:209–216, 2005.

225. Rees K, Beranek-Stanley M, Burke M, et al: Hypo-

thermia to reduce neurological damage following

coronary artery bypass surgery. Cochrane Database

Syst Rev 1:CD002138, 2001.

226. Stump DA, Jones TJ, Rorie KD: Neurophysiologic

monitoring and outcomes in cardiovascular surgery.

J Cardiothorac Vasc Anesth 13:600–613, 1999.

227. Barbut D, Hinton RB, Szatrowski TP, et al: Cerebral

emboli detected during bypass surgery are associa-

ted with clamp removal. Stroke 25:2398–2402,

1994.

228. Madl JE, Allen DL: Hyperthermia depletes adeno-

sine triphosphate and decreases glutamate uptake

in rat hippocampal slices. Neuroscience 69:395–405,

1995.

229. Castillo J, Davalos A, Noya M: Aggravation of acute

ischemic stroke by hyperthermia is related to an

excitotoxic mechanism. Cerebrovasc Dis 9:22–27,

1999.

230. Reith J, Jorgensen HS, Pedersen PM, et al: Body

temperature in acute stroke: Relation to stroke seve-

rity, infarct size, mortality, and outcome. Lancet

347:422–425, 1996.

231. Kammersgaard LP, Jorgensen HS, Rungby JA, et al:

Admission body temperature predicts long-term

mortality after acute stroke: The Copenhagen Stroke

Study. Stroke 33:1759–1762, 2002.

232. Warm Heart Investigators: Randomised trial of

normothermic versus hypothermic coronary bypass

surgery. Lancet 343, 559-563, 1994.

233. Mora CT, Henson MB, Weintraub WS, et al: The

effect of temperature management during cardio-

pulmonary bypass on neurologic and neuropsycho-

logic outcomes in patients undergoing coronary

revascularization. J Thorac Cardiovasc Surg

112:514–522, 1996.

234. Hogue CW Jr, Palin CA, Arrowsmith JE: Cardiopul-

monary bypass management and neurologic outco-

mes: An evidence-based appraisal of current

practices. Anesth Analg 103:21–37, 2006.

Anestesia para los procedimientos de cirugía cardíaca

1735

Sección IV

Anestesia por subespecialidades en el adulto